New hope for leukemia patients who have run out of options
NCT ID NCT05263284
Summary
This early-stage trial is testing whether combining a new drug called 8-chloroadenosine with an existing cancer drug (venetoclax) is safe and tolerable for adults with acute myeloid leukemia that has come back or stopped responding to other treatments. The main goal is to find the right dose and understand side effects, while also seeing if this combination can help control the cancer. About 30 participants will receive the treatment in cycles for up to four months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.